投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
22820.0元/篇
（网友贡献，非官方数据）
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
1.6 %
年文章数
3508
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
Molecular and Cellular Biochemistry: An International Journal for Chemical Biology in Health and Disease publishes original research papers, short communications, and state-of-the-art reviews in all areas of the biomedical sciences, emphasizing novel findings relevant to the molecular and cellular basis of human disease. The aim of the journal is to publish papers that describe new insights and advances in basic molecular biology, cellular biology, biochemistry, pharmacology, physiology, translational research, and also in clinical trials that illuminate to the basic mechanisms of disease. The scope of MCB is not restricted to bench or animal studies, but it includes also human studies because, in the ultimate analysis, the best model to study human disease is humans.
In addition to original basic research reports, the journal publishes:
State-of-the-art Reviews
Methodological papers that describe new enabling technologies
Translational studies that use preclinical models to evaluate new therapies or diagnostic methods as a step to eventually bring this knowledge to a first-in-human clinical trial
Clinical studies that elucidate the fundamental mechanisms of human disease. The journal does not publish clinical trials or studies of drug efficacy or clinical outcome, but rather studies that use human subjects to interrogate the molecular and cellular mechanisms of disease or studies that provide new information on the mechanism of action of therapies used in clinical practice.
Editor-in-Chief Emeritus
Dr. Naranjan Dhalla, Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Canada
